SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc.
MNTA 52.480.0%Oct 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: idos who wrote (2837)10/24/2011 5:33:12 PM
From: tuck  Read Replies (1) of 3027
 
I was not expecting this until Amphastar or Teva hit the market. This is presumably triggered by Sanofi believing that Amphastar is, in fact, going to launch this quarter. What is especially odd is that Sanofi could have waited one more day, or at most one more week, and probably gotten more clarity on that belief.

Thoughts? Does this affect damages/settlement terms from Amphastar? Would Sanofi unlaunch if MNTA gets its PI? What happens to the MNTA Sandoz terms then?

TIA & Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext